AJANTA PHARMA LTD. - Outcome of Board Meeting

At the Board meeting held today, the Board has inter alia approved and taken on record Unaudited Financial results for the second quarter and half year ended 30th September 2017. Pursuant to Regulation 33 the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the following:<BR> <BR> i. Press Release being issued on the Results for the second quarter and half year ended 30th September 2017;<BR> ii. Unaudited Consolidated Financial Results for the second quarter and half year ended 30th September 2017;<BR> iii. Limited Review Report from Auditors M/s BSR & Co. LLP on the unaudited Consolidated Financial Results for the second quarter and half year ended 30th September 2017;<BR> iv. Unaudited Standalone Financial Results for the second quarter and half year ended 30th September 2017;<BR> v. Limited Review Report from Auditors M/s BSR & Co. LLP on the unaudited Standalone Financial Results for the second quarter and half year ended 30th September 2017.<BR>